Comment from Eli Lilly and Company

Comment

See attached file(s)

Attachments

 (1)

Comment from Eli Lilly and Company

View Attachment:
Authors: cder
 

 
 
Comment Period Closed
Apr 14 2014, at 11:59 PM ET
ID: FDA-2013-N-1430-0006
Tracking Number: 1jy-8bbu-2oc4

Document Information

Date Posted: Apr 15, 2014
Show More Details  

Submitter Information

Country: United States
State or Province: IN
Category: Drug Industry - C0022